Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy

European Journal of Cancer Care

Volumn 17, Issue 6, 2008, Pages 535-541

  Iconomou, G ^a   Koutras, A ^a   Karaivazoglou, K ^a   Kalliolias, G D ^a   Assimakopoulos, K ^a   Argyriou, A A ^a   Ifanti, A ^b   Kalofonos, H P ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Anaemia; Chemotherapy; Cognitive function; Epoetin alfa; Quality of life

Indexed keywords

ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG ADMINISTRATION; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; QUALITY OF LIFE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; EPOETIN ALFA; FATIGUE; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 54349119374     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2007.00857.x     Document Type: Article

References (32)

1. Aaronson N.K., Ahmedzai S., Bullinger M., Crabeels D., Estape J., Filiberti A., Fletchner H., Frick U., Hurny C., Kaasa S., Klee M., Mastilica M., Osoba D., Pfausler Razavi D., Rofe B.C., Schraub S., Sullivan M. Takeda F. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85, 365 375.
2. Bamias A., Aravantinos G., Kalofonos C., Timotheadou N., Siafaka V., Vlahou I., Janinis D., Pectasides D., Pavlidis N. Fountzilas G. (2003) Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group. Oncology 64, 102 110.
3. Bohlius J., Wilson J., Seidenfeld J., Piper M., Schwarzer G., Sandercock J., Trelle S., Weingart O., Bayliss S., Djulbegovic B., Bennett C.L., Langensiepen S., Hyde C. Engert A. (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. Journal of the National Cancer Institute 98, 708 714.
4. Bokemeyer C., Aapro M.S., Courdi A., Foubert J., Link H., Osterborg A., Repetto L. Soubeyran P. (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. European Journal of Cancer 40, 2201 2216.
5. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M. Cerami A. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences of the United States of America 97, 10526 10531.
6. Cunningham R.S. (2003) Anemia in the oncology patient. Cancer Nursing 26, 38 42.
7. Desai J. Demetri G.D. (2005) Recombinant human erythropoietin in cancer-related anemia: an evidence-based review. Best Practice and Research. Clinical Haematology 18, 389 406.
8. Ehrenreich H., Aust C., Krampe H., Jahn H., Jacob S., Herrmann M. Siren A. (2004) Erythropoietin: Novel approaches to neuroprotection in human brain disease. Metabolic Brain Disease 19, 195 206.
9. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De Ryck M., Itri L., Prange H., Cerami A., Brines M. Siren A.L. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Molecular Medicine 8, 495 505.
10. Ferrario E., Ferrari L., Bidoli P., De Candis D., Del Vecchio M., De Dosso S., Buzzoni R. Bajetta E. (2004) Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treatment Reviews 30, 563 575.
11. Folstein M.F., Folstein S.E. McHugh P.R. (1975) 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189 198.
12. Fountoulakis K., Tsolaki M., Chantzi H. Kazis A. (2000) Mini Mental State Examination (MMSE): a validation study in Greece. American Journal of Alzheimer's Disease 15, 342 345.
13. Grimm G., Stockenhuber F., Schneeweiss B., Madl C., Zeitlhofer J. Schneider B. (1990) Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney International 38, 480 486.
14. Henry D. (2004) The evolving role of epoetin alfa in cancer therapy. Oncologist 9, 97 107.
15. Heras P., Argyriou A.A., Papapetropoulos S., Karagiannis S., Argyriou K. Mitsibounas D. (2005) The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anaemic cancer patients. European Journal of Cancer Care 14, 108 112.
16. Iconomou G., Koutras A., Rigopoulos A., Vagenakis A.G. Kalofonos H.P. (2003) Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial. Journal of Pain and Symptom Management 25, 512 518.
17. Jacobsen P.B., Garland L.L., Booth-Jones M., Donovan K., Thors C., Winters E. Grendys E. (2004) Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. Journal of Pain and Symptom Management 28, 7 18.
18. Libretto S.E., Barrett-Lee P.J., Branson K., Gorst D.W., Kaczmarski R., Mcadam K., Stevenson P. Thomas R. (2001) Improvement in quality of life for cancer patients treated with epoetin alfa. European Journal of Cancer Care 10, 183 191.
19. Mancuso A., Migliorino M., De Santis S., Saponiero A. De Marinis F. (2006) Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology 17, 146 150.
20. Marsh J.T., Brown W.S., Wolcott D., Carr C.R., Harper R., Schweitzer S.V. Nissenson A.R. (1991) rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney International 39, 155 163.
21. Massa E., Madeddu C., Lusso M.R., Gramignano G. Mantovani G. (2006) Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology 57, 175 182.
22. Meyers C.A. Wefel J.S. (2003) The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts or sensitivity. Journal of Clinical Oncology 21, 3557 3558.
23. Milano M. Collomp R. (2005) Erythropoietin and neuroprotection: a therapeutic perspective. Journal of Oncology Pharmacy Practice 11, 145 149.
24. O'Shaughnessy J.A., Vukelja S.J., Holmes F.A., Savin M., Jones M., Royall D., George M. Von Hoff D. (2005) Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clinical Breast Cancer 5, 439 446.
25. Philips K.A. Bernhard J. (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute 95, 190 197.
26. Pickett J.L., Theberge D.C., Brown W.S., Schweitzer S.U. Nissenson A.R. (1999) Normalizing hematocrit in dialysis patients improves brain function. American Journal of Kidney Diseases 33, 1122 1130.
27. Poppelreuter M., Weis J., Kulz A.K., Tucha O., Lange K.W. Bartsch H.H. (2004) Cognitive dysfunction and subjective complaints of cancer patients: a cross-sectional study in a cancer rehabilitation centre. European Journal of Cancer 40, 43 49.
28. Rugo H.S. Ahles T. (2003) The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Seminars in Oncology 30, 749 762.
29. Seidenfeld J., Piper M., Flamm C., Hasselblad V., Armitage J.O., Bennett C.L., Gordon M.S., Lichtin A.E., Wade J.L., 3rd Woolf S. Aronson N. (2001) Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. Journal of the National Cancer Institute 93, 1204 1214.
30. Shasha D. Williams D. (2006) Weekly epoetin alfa treatment of anemia in patients with cancer not undergoing therapy. Journal of Supportive Oncology 4, 129 135.
31. Tchen N., Juffs H.G., Downie F.P., Yi Q., Hu H., Chemerynsky I., Clemons M., Crump M., Goss P.E., Warr D., Tweedale M.E. Tannock I.F. (2003) Cognitive function, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 21, 4175 4183.
32. Waltzman R., Croot C., Justice J.R., Fesen M.R., Charu V. Williams D. (2005) Randomized comparison of epoetin alfa (40000 U weekly) and darbepoetin alfa (200μg every 2 weeks) in anemic patients with cancer receiving chemotherapy. Oncologist 10, 642 650.